VITALE, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 306
EU - Europa 170
AS - Asia 161
SA - Sud America 4
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 643
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 305
IT - Italia 86
SG - Singapore 82
CN - Cina 25
HK - Hong Kong 22
DE - Germania 19
ID - Indonesia 19
FI - Finlandia 15
RU - Federazione Russa 14
SE - Svezia 10
GB - Regno Unito 9
LT - Lituania 6
IN - India 4
JP - Giappone 4
IR - Iran 3
BR - Brasile 2
ES - Italia 2
HU - Ungheria 2
NL - Olanda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BG - Bulgaria 1
CA - Canada 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IE - Irlanda 1
KZ - Kazakistan 1
MA - Marocco 1
PH - Filippine 1
Totale 643
Salva come PNG Salva come JPEG
Città #
Santa Clara 188
Singapore 76
New York 20
Jakarta 19
Hong Kong 18
Ashburn 16
Helsinki 14
Parma 13
Seattle 12
Chandler 11
Bologna 7
Moscow 7
Nyköping 7
Chieti 6
Fornovo di Taro 6
Frankfurt am Main 6
Fairfield 5
Milan 5
Modena 4
Rome 4
Ann Arbor 3
Bremen 3
Reggio Emilia 3
Shanghai 3
Beijing 2
Cambridge 2
Castagneto 2
Castel Bolognese 2
Chicago 2
Ergolding 2
Forlì 2
Francavilla al Mare 2
Hounslow 2
Houston 2
Kilburn 2
Los Angeles 2
Montevideo 2
Nuremberg 2
Pavullo Nel Frignano 2
San Benedetto del Tronto 2
Suzuka 2
Wan Chai 2
Woodbridge 2
Almaty 1
Americana 1
Amsterdam 1
Athens 1
Bresso 1
Cheyenne 1
Chiswick 1
Ciampino 1
Collado Villalba 1
Dublin 1
Ferrara 1
Guelph 1
Hamburg 1
Lappeenranta 1
London 1
Madrid 1
Manila 1
Mumbai 1
Munich 1
Nagpur 1
Nave 1
Newark 1
Noida 1
Osaka 1
Pingdingshan 1
Prague 1
Prescot 1
Princeton 1
Pune 1
Rabat 1
Reggio Nell'emilia 1
Salt Lake City 1
San Diego 1
San Mateo 1
Sofia 1
Spokane 1
St. George 1
Stockholm 1
Warwick 1
Xuzhou 1
Totale 534
Salva come PNG Salva come JPEG
Nome #
Linc00941 is a novel TGFβ target that primes papillary thyroid cancer metastatic behavior by regulating the expression of Cadherin 6 127
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2 73
KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM) 60
Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis 50
Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma 47
OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer 38
Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin 37
Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy 33
Caratterizzazione approfondita della rete trascrizionale di RUNX2 nei tumori tiroidei: meccanismo d'azione e conseguenze biologiche 32
HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression 31
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer: insights into mitochondrial modulation 28
No Need to Stick Together to Be Connected: Multiple Types of Enhancers' Networking 25
The pancancer overexpressed NFYCAntisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action 24
Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma 21
Corrigendum: Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy(Front. Oncol., (2023), 13, (1257622), 10.3389/fonc.2023.1257622) 20
Exploring the transcriptional cooperation between RUNX2 and its associated elncRNA RAIN 18
Totale 664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.534
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/202228 11 1 0 1 0 3 0 2 1 3 5 1
2022/202368 1 6 2 3 14 10 13 4 7 2 4 2
2023/2024170 6 9 15 9 19 34 11 22 6 7 14 18
2024/2025386 16 12 18 38 161 141 0 0 0 0 0 0
Totale 664